Drugs / Lu AF88370
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05320302 | Mar → Jun 2022 | — | H. Lundbeck A/S | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lu AF88370 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05320302 ↗ |
| Known as | [11C]-Lu AF88370 | “Interventional, Open-Label, Positron Emission Tomography (PET) Study With [11C]-Lu AF88370 Investigating Blood-Brain Barrier Penetration of Lu AF88370 in Healthy Men” NCT05320302 ↗ |
| Route | Intravenous | “single intravenous bolus injection” NCT05320302 ↗ |